aluates Reports

$ 0.0

Automative

Spinal Muscular Atrophy (SMA) Treatment - Global Market Insights and Sales Trends 2024

Published Date: December 2023

Report Code: QYRE-Auto-7W2422

Global Spinal Muscular Atrophy SMA Treatment Market Insights and Forecast to 2028

BUY CHAPTERS

Spinal Muscular Atrophy (SMA) Treatment - Global Market Insights and Sales Trends 2024

Code: QYRE-Auto-7W2422

Report

December 2023

Pages:86

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

Regeneron Pharmaceuticals

Spinal Muscular Atrophy (SMA) Treatment - Market Size

The global Spinal Muscular Atrophy (SMA) Treatment market size is expected to reach US$ 1546.6 million by 2029, growing at a CAGR of 7.3% from 2023 to 2029.

Spinal Muscular Atrophy (SMA) Treatment - Market

Spinal muscular atrophy (SMA) refers to a group of inherited diseases that affects the functioning of muscles because of deterioration.

The market is mainly driven by the significant applications of Spinal Muscular Atrophy (SMA) Treatment in various end use industries. The expanding demands from the Hospitals, Ambulatory Surgical Centers, Diagnostic Centers and Others, are propelling Spinal Muscular Atrophy (SMA) Treatment market. Type I Spinal Muscular Atrophy (SMA), one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Type II Spinal Muscular Atrophy (SMA) segment is estimated at % CAGR for the next seven-year period.

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

Report Objectives

This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Spinal Muscular Atrophy (SMA) Treatment, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.

Key Features of The Study:

This report provides in-depth analysis of the global Spinal Muscular Atrophy (SMA) Treatment market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.

This report profiles key players in the global Spinal Muscular Atrophy (SMA) Treatment market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Spinal Muscular Atrophy (SMA) Treatment sales data, market share and ranking.

This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.

This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.

Key companies of Spinal Muscular Atrophy (SMA) Treatment covered in this report include Pfizer, Isis Pharmaceuticals, Biogen Idec, Boehringer Ingelheim, F. Hoffmann-La Roche and Regeneron Pharmaceuticals, etc.

The global Spinal Muscular Atrophy (SMA) Treatment market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.

Market Segmentation

Company Profiles:

Pfizer

Isis Pharmaceuticals

Biogen Idec

Boehringer Ingelheim

F. Hoffmann-La Roche

Regeneron Pharmaceuticals

Scope of Spinal Muscular Atrophy (SMA) Treatment - Market Report

Report Metric	Details
Report Name	Spinal Muscular Atrophy (SMA) Treatment - Market
Forecasted market size in 2029	US$ 1546.6 million
CAGR	7.3%
Forecasted years	2023 - 2029
Global Spinal Muscular Atrophy (SMA) Treatment market, by region:	North America (U.S., Canada, Mexico) Europe (Germany, France, UK, Italy, etc.) Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.) South America (Brazil, etc.) Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Spinal Muscular Atrophy (SMA) Treatment market, Segment by Type:	Type I Spinal Muscular Atrophy (SMA) Type II Spinal Muscular Atrophy (SMA) Type III Spinal Muscular Atrophy (SMA)
Global Spinal Muscular Atrophy (SMA) Treatment market, by Application	Hospitals Ambulatory Surgical Centers Diagnostic Centers Others
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Spinal Muscular Atrophy (SMA) Treatment companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion

FAQ for this report

What is the Spinal Muscular Atrophy (SMA) Treatment - Market size in 2029?

Ans: The Spinal Muscular Atrophy (SMA) Treatment - Market size in 2029 will be US$ 1546.6 million.

What are the Application segmentation covered in the Spinal Muscular Atrophy (SMA) Treatment - Market report?

Ans: The Applications covered in the Spinal Muscular Atrophy (SMA) Treatment - Market report are Hospitals, Ambulatory Surgical Centers, Diagnostic Centers, Others

What are the Type segmentation covered in the Spinal Muscular Atrophy (SMA) Treatment - Market report?

Ans: The Types covered in the Spinal Muscular Atrophy (SMA) Treatment - Market report are Type I Spinal Muscular Atrophy (SMA), Type II Spinal Muscular Atrophy (SMA), Type III Spinal Muscular Atrophy (SMA)

1 Market Overview of Spinal Muscular Atrophy (SMA) Treatment

1.1 Spinal Muscular Atrophy (SMA) Treatment Market Overview

1.1.1 Spinal Muscular Atrophy (SMA) Treatment Product Scope

1.1.2 Spinal Muscular Atrophy (SMA) Treatment Market Status and Outlook

1.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Overview by Region 2018 VS 2022 VS 2029

1.3 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2018-2029)

1.4 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Region (2018-2023)

1.5 Global Spinal Muscular Atrophy (SMA) Treatment Market Size Forecast by Region (2024-2029)

1.6 Key Regions, Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029)

1.6.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029)

1.6.2 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029)

1.6.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029)

1.6.4 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029)

1.6.5 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029)

2 Spinal Muscular Atrophy (SMA) Treatment Market by Type

2.1 Introduction

2.1.1 Type I Spinal Muscular Atrophy (SMA)

2.1.2 Type II Spinal Muscular Atrophy (SMA)

2.1.3 Type III Spinal Muscular Atrophy (SMA)

2.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type: 2018 VS 2022 VS 2029

2.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Type (2018-2023)

2.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2024-2029)

2.3 Key Regions Market Size by Type

2.3.1 North America Spinal Muscular Atrophy (SMA) Treatment Revenue Breakdown by Type (2018-2029)

2.3.2 Europe Spinal Muscular Atrophy (SMA) Treatment Revenue Breakdown by Type (2018-2029)

2.3.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue Breakdown by Type (2018-2029)

2.3.4 Latin America Spinal Muscular Atrophy (SMA) Treatment Revenue Breakdown by Type (2018-2029)

2.3.5 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue Breakdown by Type (2018-2029)

3 Spinal Muscular Atrophy (SMA) Treatment Market Overview by Application

3.1 Introduction

3.1.1 Hospitals

3.1.2 Ambulatory Surgical Centers

3.1.3 Diagnostic Centers

3.1.4 Others

3.2 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Application: 2018 VS 2022 VS 2029

3.2.1 Global Spinal Muscular Atrophy (SMA) Treatment Historic Market Size by Application (2018-2023)

3.2.2 Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2024-2029)

3.3 Key Regions Market Size by Application

3.3.1 North America Spinal Muscular Atrophy (SMA) Treatment Revenue Breakdown by Application (2018-2029)

3.3.2 Europe Spinal Muscular Atrophy (SMA) Treatment Revenue Breakdown by Application (2018-2029)

3.3.3 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue Breakdown by Application (2018-2029)

3.3.4 Latin America Spinal Muscular Atrophy (SMA) Treatment Revenue Breakdown by Application (2018-2029)

3.3.5 Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue Breakdown by Application (2018-2029)

4 Spinal Muscular Atrophy (SMA) Treatment Competition Analysis by Players

4.1 Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Players (2018-2023)

4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2022)

4.3 Date of Key Players Enter into Spinal Muscular Atrophy (SMA) Treatment Market

4.4 Global Top Players Spinal Muscular Atrophy (SMA) Treatment Headquarters and Area Served

4.5 Key Players Spinal Muscular Atrophy (SMA) Treatment Product Solution and Service

4.6 Competitive Status

4.6.1 Spinal Muscular Atrophy (SMA) Treatment Market Concentration Rate

4.6.2 Mergers & Acquisitions, Expansion Plans

5 Company (Top Players) Profiles

5.1 Pfizer

5.1.1 Pfizer Profile

5.1.2 Pfizer Main Business

5.1.3 Pfizer Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

5.1.4 Pfizer Spinal Muscular Atrophy (SMA) Treatment Revenue (US$ Million) & (2018-2023)

5.1.5 Pfizer Recent Developments

5.2 Isis Pharmaceuticals

5.2.1 Isis Pharmaceuticals Profile

5.2.2 Isis Pharmaceuticals Main Business

5.2.3 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

5.2.4 Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue (US$ Million) & (2018-2023)

5.2.5 Isis Pharmaceuticals Recent Developments

5.3 Biogen Idec

5.3.1 Biogen Idec Profile

5.3.2 Biogen Idec Main Business

5.3.3 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

5.3.4 Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Revenue (US$ Million) & (2018-2023)

5.3.5 Boehringer Ingelheim Recent Developments

5.4 Boehringer Ingelheim

5.4.1 Boehringer Ingelheim Profile

5.4.2 Boehringer Ingelheim Main Business

5.4.3 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

5.4.4 Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Revenue (US$ Million) & (2018-2023)

5.4.5 Boehringer Ingelheim Recent Developments

5.5 F. Hoffmann-La Roche

5.5.1 F. Hoffmann-La Roche Profile

5.5.2 F. Hoffmann-La Roche Main Business

5.5.3 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

5.5.4 F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Revenue (US$ Million) & (2018-2023)

5.5.5 F. Hoffmann-La Roche Recent Developments

5.6 Regeneron Pharmaceuticals

5.6.1 Regeneron Pharmaceuticals Profile

5.6.2 Regeneron Pharmaceuticals Main Business

5.6.3 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

5.6.4 Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Revenue (US$ Million) & (2018-2023)

5.6.5 Regeneron Pharmaceuticals Recent Developments

6 North America

6.1 North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2018-2029)

6.2 U.S.

6.3 Canada

7 Europe

7.1 Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2018-2029)

7.2 Germany

7.3 France

7.4 U.K.

7.5 Italy

7.6 Russia

7.7 Nordic Countries

7.8 Rest of Europe

8 Asia-Pacific

8.1 Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2018-2029)

8.2 China

8.3 Japan

8.4 South Korea

8.5 Southeast Asia

8.6 India

8.7 Australia

8.8 Rest of Asia-Pacific

9 Latin America

9.1 Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2018-2029)

9.2 Mexico

9.3 Brazil

9.4 Rest of Latin America

10 Middle East & Africa

10.1 Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2018-2029)

10.2 Turkey

10.3 Saudi Arabia

10.4 UAE

10.5 Rest of Middle East & Africa

11 Spinal Muscular Atrophy (SMA) Treatment Market Dynamics

11.1 Spinal Muscular Atrophy (SMA) Treatment Industry Trends

11.2 Spinal Muscular Atrophy (SMA) Treatment Market Drivers

11.3 Spinal Muscular Atrophy (SMA) Treatment Market Challenges

11.4 Spinal Muscular Atrophy (SMA) Treatment Market Restraints

12 Research Finding /Conclusion

13 Methodology and Data Source

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

13.4 Author List

FEATURED COMPANIES

Regeneron Pharmaceuticals

List of Tables

Table 1. Global Market Spinal Muscular Atrophy (SMA) Treatment Market Size (US$ Million) Comparison by Region 2018 VS 2022 VS 2029

Table 2. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2018-2023) & (US$ Million)

Table 3. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Region (2018-2023)

Table 4. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)

Table 5. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size Share by Region (2024-2029)

Table 6. Global Spinal Muscular Atrophy (SMA) Treatment Market Size (US$ Million) by Type: 2018 VS 2022 VS 2029

Table 7. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Type (2018-2023) & (US$ Million)

Table 8. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2018-2023)

Table 9. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)

Table 10. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2024-2029)

Table 11. North America Spinal Muscular Atrophy (SMA) Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 12. North America Spinal Muscular Atrophy (SMA) Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 13. Europe Spinal Muscular Atrophy (SMA) Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 14. Europe Spinal Muscular Atrophy (SMA) Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 15. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 16. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 17. Latin America Spinal Muscular Atrophy (SMA) Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 18. Latin America Spinal Muscular Atrophy (SMA) Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 19. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue by Type (2018-2023) & (US$ Million)

Table 20. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue by Type (2024-2029) & (US$ Million)

Table 21. Global Spinal Muscular Atrophy (SMA) Treatment Market Size (US$ Million) by Application: 2018 VS 2022 VS 2029

Table 22. Global Spinal Muscular Atrophy (SMA) Treatment Market Size by Application (2018-2023) & (US$ Million)

Table 23. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2018-2023)

Table 24. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)

Table 25. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2024-2029)

Table 26. North America Spinal Muscular Atrophy (SMA) Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 27. North America Spinal Muscular Atrophy (SMA) Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 28. Europe Spinal Muscular Atrophy (SMA) Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 29. Europe Spinal Muscular Atrophy (SMA) Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 30. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 31. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 32. Latin America Spinal Muscular Atrophy (SMA) Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 33. Latin America Spinal Muscular Atrophy (SMA) Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 34. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue by Application (2018-2023) & (US$ Million)

Table 35. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue by Application (2024-2029) & (US$ Million)

Table 36. Global Spinal Muscular Atrophy (SMA) Treatment Revenue (US$ Million) by Players (2018-2023)

Table 37. Global Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Players (2018-2023)

Table 38. Global Top Players Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Spinal Muscular Atrophy (SMA) Treatment as of 2022)

Table 39. Date of Key Players Enter into Spinal Muscular Atrophy (SMA) Treatment Market

Table 40. Global Spinal Muscular Atrophy (SMA) Treatment Key Players Headquarters and Area Served

Table 41. Spinal Muscular Atrophy (SMA) Treatment Product Solution and Service

Table 42. Global Spinal Muscular Atrophy (SMA) Treatment Players Market Concentration Ratio (CR5 and HHI)

Table 43. Mergers & Acquisitions, Expansion Plans

Table 44. Pfizer Basic Information List

Table 45. Pfizer Description and Business Overview

Table 46. Pfizer Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

Table 47. Revenue (US$ Million) in Spinal Muscular Atrophy (SMA) Treatment Business of Pfizer (2018-2023)

Table 48. Pfizer Recent Developments

Table 49. Isis Pharmaceuticals Basic Information List

Table 50. Isis Pharmaceuticals Description and Business Overview

Table 51. Isis Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

Table 52. Revenue (US$ Million) in Spinal Muscular Atrophy (SMA) Treatment Business of Isis Pharmaceuticals (2018-2023)

Table 53. Isis Pharmaceuticals Recent Developments

Table 54. Biogen Idec Basic Information List

Table 55. Biogen Idec Description and Business Overview

Table 56. Biogen Idec Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

Table 57. Revenue (US$ Million) in Spinal Muscular Atrophy (SMA) Treatment Business of Biogen Idec (2018-2023)

Table 58. Biogen Idec Recent Developments

Table 59. Boehringer Ingelheim Basic Information List

Table 60. Boehringer Ingelheim Description and Business Overview

Table 61. Boehringer Ingelheim Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

Table 62. Revenue (US$ Million) in Spinal Muscular Atrophy (SMA) Treatment Business of Boehringer Ingelheim (2018-2023)

Table 63. Boehringer Ingelheim Recent Developments

Table 64. F. Hoffmann-La Roche Basic Information List

Table 65. F. Hoffmann-La Roche Description and Business Overview

Table 66. F. Hoffmann-La Roche Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

Table 67. Revenue (US$ Million) in Spinal Muscular Atrophy (SMA) Treatment Business of F. Hoffmann-La Roche (2018-2023)

Table 68. F. Hoffmann-La Roche Recent Developments

Table 69. Regeneron Pharmaceuticals Basic Information List

Table 70. Regeneron Pharmaceuticals Description and Business Overview

Table 71. Regeneron Pharmaceuticals Spinal Muscular Atrophy (SMA) Treatment Products, Services and Solutions

Table 72. Revenue (US$ Million) in Spinal Muscular Atrophy (SMA) Treatment Business of Regeneron Pharmaceuticals (2018-2023)

Table 73. Regeneron Pharmaceuticals Recent Developments

Table 74. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 75. North America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 76. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 77. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 78. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 79. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2018-2023) & (US$ Million)

Table 80. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size by Region (2024-2029) & (US$ Million)

Table 81. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2018-2023)

Table 82. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2024-2029)

Table 83. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 84. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 85. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 86. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029

Table 87. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2018-2023) & (US$ Million)

Table 88. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size by Country (2024-2029) & (US$ Million)

Table 89. Spinal Muscular Atrophy (SMA) Treatment Market Trends

Table 90. Spinal Muscular Atrophy (SMA) Treatment Market Drivers

Table 91. Spinal Muscular Atrophy (SMA) Treatment Market Challenges

Table 92. Spinal Muscular Atrophy (SMA) Treatment Market Restraints

Table 93. Research Programs/Design for This Report

Table 94. Key Data Information from Secondary Sources

Table 95. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Year-over-Year 2018-2029 & (US$ Million)

Figure 2. Global Spinal Muscular Atrophy (SMA) Treatment Market Size (US$ Million), 2018 VS 2022 VS 2029

Figure 3. Global Spinal Muscular Atrophy (SMA) Treatment Market Share by Regions: 2022 VS 2029

Figure 4. Global Spinal Muscular Atrophy (SMA) Treatment Forecasted Market Size Share by Region (2024-2029)

Figure 5. North America Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 6. Europe Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 7. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 8. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 9. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Size Growth Rate (2018-2029) & (US$ Million)

Figure 10. Product Picture of Type I Spinal Muscular Atrophy (SMA)

Figure 11. Global Type I Spinal Muscular Atrophy (SMA) Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 12. Product Picture of Type II Spinal Muscular Atrophy (SMA)

Figure 13. Global Type II Spinal Muscular Atrophy (SMA) Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 14. Product Picture of Type III Spinal Muscular Atrophy (SMA)

Figure 15. Global Type III Spinal Muscular Atrophy (SMA) Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 16. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Type: 2022 & 2029

Figure 17. North America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2018-2029)

Figure 18. Europe Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2018-2029)

Figure 19. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2018-2029)

Figure 20. Latin America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2018-2029)

Figure 21. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Type (2018-2029)

Figure 22. Hospitals Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 23. Ambulatory Surgical Centers Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 24. Diagnostic Centers Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 25. Others Market Size (US$ Million) & YoY Growth (2018-2029)

Figure 26. Global Spinal Muscular Atrophy (SMA) Treatment Market Size Share by Application: 2022 & 2029

Figure 27. North America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2018-2029)

Figure 28. Europe Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2018-2029)

Figure 29. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2018-2029)

Figure 30. Latin America Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2018-2029)

Figure 31. Middle East and Africa Spinal Muscular Atrophy (SMA) Treatment Revenue Market Share by Application (2018-2029)

Figure 32. Spinal Muscular Atrophy (SMA) Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

Figure 33. Global Top 5 and Top 10 Players Spinal Muscular Atrophy (SMA) Treatment Market Share in 2022

Figure 34. North America Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2018-2029)

Figure 35. U.S. Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 36. Canada Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 37. Germany Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 38. France Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 39. U.K. Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 40. Italy Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 41. Russia Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 42. Nordic Countries Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 43. Asia-Pacific Spinal Muscular Atrophy (SMA) Treatment Market Share by Region (2018-2029)

Figure 44. China Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 45. Japan Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 46. South Korea Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 47. Southeast Asia Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 48. India Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 49. Australia Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 50. Latin America Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2018-2029)

Figure 51. Mexico Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 52. Brazil Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 53. Middle East & Africa Spinal Muscular Atrophy (SMA) Treatment Market Share by Country (2018-2029)

Figure 54. Turkey Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 55. Saudi Arabia Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 56. UAE Spinal Muscular Atrophy (SMA) Treatment Market Size (2018-2029) & (US$ Million)

Figure 57. Bottom-up and Top-down Approaches for This Report

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$3350

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$5025

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$6700

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions